Marshall Financial Group LLC bought a new position in Chemed Co. (NYSE:CHE) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 1,341 shares of the company’s stock, valued at approximately $636,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. LPL Financial LLC raised its stake in Chemed by 84.3% in the fourth quarter. LPL Financial LLC now owns 2,044 shares of the company’s stock valued at $1,089,000 after purchasing an additional 935 shares in the last quarter. Schroder Investment Management Group lifted its stake in Chemed by 22.5% in the fourth quarter. Schroder Investment Management Group now owns 67,641 shares of the company’s stock worth $36,026,000 after acquiring an additional 12,432 shares during the period. Amundi Pioneer Asset Management Inc. lifted its stake in Chemed by 66.0% in the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 156 shares of the company’s stock worth $83,000 after acquiring an additional 62 shares during the period. Guggenheim Capital LLC raised its position in shares of Chemed by 78.4% in the 4th quarter. Guggenheim Capital LLC now owns 3,500 shares of the company’s stock worth $1,864,000 after purchasing an additional 1,538 shares during the last quarter. Finally, Morgan Stanley raised its position in shares of Chemed by 114.9% in the 4th quarter. Morgan Stanley now owns 65,047 shares of the company’s stock worth $34,645,000 after purchasing an additional 34,775 shares during the last quarter. Institutional investors own 88.72% of the company’s stock.
In other news, Director Thomas P. Rice sold 841 shares of the business’s stock in a transaction that occurred on Thursday, June 17th. The stock was sold at an average price of $462.47, for a total transaction of $388,937.27. Following the transaction, the director now owns 5,188 shares of the company’s stock, valued at approximately $2,399,294.36. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 3,000 shares of the company’s stock in a transaction on Friday, June 4th. The shares were sold at an average price of $497.61, for a total value of $1,492,830.00. Following the completion of the transaction, the chief executive officer now directly owns 131,688 shares in the company, valued at approximately $65,529,265.68. The disclosure for this sale can be found here. Over the last three months, insiders sold 9,549 shares of company stock worth $4,627,366. 3.69% of the stock is owned by insiders.
Several equities research analysts recently commented on the company. Royal Bank of Canada lifted their price objective on Chemed from $604.00 to $609.00 and gave the stock an “outperform” rating in a report on Thursday. Zacks Investment Research upgraded Chemed from a “hold” rating to a “buy” rating and set a $496.00 price target for the company in a research note on Thursday, April 29th.
Shares of NYSE:CHE opened at $476.02 on Monday. The company’s 50 day moving average is $480.95. The company has a market cap of $7.59 billion, a P/E ratio of 25.01, a PEG ratio of 3.53 and a beta of 0.47. Chemed Co. has a 12-month low of $417.41 and a 12-month high of $560.00.
Chemed (NYSE:CHE) last announced its quarterly earnings data on Monday, July 26th. The company reported $4.60 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $4.29 by $0.31. The company had revenue of $532.26 million during the quarter, compared to the consensus estimate of $511.85 million. Chemed had a return on equity of 35.40% and a net margin of 14.30%. The firm’s revenue was up 6.0% on a year-over-year basis. During the same period in the previous year, the company posted $4.41 EPS. As a group, sell-side analysts expect that Chemed Co. will post 17.9 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 16th. Investors of record on Thursday, May 27th were issued a $0.34 dividend. The ex-dividend date was Wednesday, May 26th. This represents a $1.36 dividend on an annualized basis and a yield of 0.29%. Chemed’s dividend payout ratio is presently 7.52%.
Chemed Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations.
Further Reading: Stop Order Uses For Individual Investors